Target Name: LOC107987299
NCBI ID: G107987299
Other Name(s): uncharacterized LOC107987299 | LOC107987299 variant X1 | Uncharacterized LOC107987299, transcript variant X1

LOC107987299: A Potential Drug Target and Biomarker

LOC107987299 is a unique genetic code, which has not yet been assigned a specific function or a corresponding protein. However, research into the genetics and epigenetics of this gene has shed light on its potential role in various diseases, including cancer. Its unique sequence has also piqued the interest of researchers, who are investigating its potential as a drug target or biomarker.

The LOC107987299 gene is located on chromosome 19, which contains over 20,000 genes. The gene is made up of 20 exons, and its last exon is a splice variant, which means it can produce different proteins depending on the specific conditions.

One of the most interesting aspects of the LOC107987299 gene is its expression pattern. Studies have shown that the gene is highly expressed in various tissues and organs, including the brain, heart, liver, and pancreas. It is also expressed in the placenta, which suggests a possible role in fetal development.

The gene has also been linked to several diseases, including cancer. Studies have shown that LOC107987299 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that it may be a useful biomarker for these diseases.

In addition to its potential as a drug target or biomarker, LOC107987299 is also of interest as a potential therapeutic target for other diseases. The gene has been shown to be involved in several cellular processes, including cell adhesion, migration, and invasion. This suggests that it may be a useful target for drugs that are designed to disrupt these processes.

Furthermore, the LOC107987299 gene has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of cancer. Studies have shown that the gene is involved in the regulation of cell cycle progression, apoptosis, and angiogenesis. This suggests that it may be a useful target for drugs that are designed to inhibit these processes.

In conclusion, LOC107987299 is a unique and fascinating gene that has the potential to be a drug target or biomarker. Its unique expression pattern and its involvement in various diseases, including cancer, make it an attractive target for further research. Further studies are needed to fully understand its potential role in these diseases and to explore its potential as a therapeutic target.

Protein Name: Uncharacterized LOC107987299

More Common Targets

LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512